维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Veliceasa"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Percutaneous pinning for proximal humerus fractures显示文摘	Alexa O Puha B Veliceasa B	2007	Rev Med Chir Soc Med Nat Lasi2007，111，1：	1
2	Metronomic low -dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT -510:a complementation antiangiogenic strategy显示文摘	Yap R Veliceasa D Emmenegger U	2005	Clin Cancer Res2005，11，18：	1
3	miR-27b controls venous specification and tip cell fate显示文摘	Biyashev D Veliceasa D Topczewski J	2012	Blood2012，119，：	1
4	Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma(PPARgamma)显示文摘	Biyashev D Veliceasa D Kwiatek A	2010	J Biol Chem2010，285，13：	1
5	Percutaneous Herbert screw osteosyn thesis in trans-scaphoid perilunate fracture-dislocations显示文摘	Alexa O Veliceasa B	2013	Rev Med Chir Soc Med Nat Iasi2013，117，40：	1
6	Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma) 显示文摘	Biyashev D Veliceasa D Liao CL	2010	Biol Chem2010，285，13：	1
7	Pigment epithelium-derived factor and interleukin-6 control prostate neuro- endocrine differentiation via feed-forward mechanism显示文摘	Smith ND Schulze-Hoepfner FT Veliceasa D	2008	J Urol2008，179，6：	1
8	Chemopreventive api- genin controls UVB-induced cutaneous proliferation and angio- genesis through HuR and thrombospondin-1显示文摘	Tong X Mirzoeva S Veliceasa D	2014	Oncotarget2014，5，11：	1
9	miR-200b inhibits prostate cancer EMT,growth and metastasis显示文摘	Williams L V Veliceasa D Vinokour E	2013	PLoS One2013，8，83：	1
10	Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma显示文摘	Veliceasa D Ivanovic M Hoepfner FT	2007	FEBS J2007，274，24：	1
11	miR-200binhibits prostate cancer EMT, growth and metastasis 显示文摘	Williams LV Veliceasa D Vinokour E	2013	PLoSOne2013，8，83：	1
12	The many facets of PEDF in drug discovery and disease:a diamond in the rough or split personality disorder显示文摘	Craword SE Fitchev P Veliceasa D	2013	Expert Opin Drug Discov2013，8，7：	1
13	Metronomic lowdose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510:a complementation antiangiogenic strategy显示文摘	Yap R Veliceasa D Emmenegger U	2005	Clin Cancer Res2005，11，18：	1
14	Metronomic chemotherapy boosts CD95-dependent antiangiogenic the thrombospondin peptideABT-510: a complementa-tion anti-angiogenic strategy 显示文摘	YAP R low-dose VELICEASA D EMMENEGGERU	2005	Clin CancerRes2005，11，18：	1
15	Metronomic low - dose chemotherapy boosts CD95 - dependent antiangiogenic effect of the thrombospondin peptide ABT -510: a complementation antiangiogenic strategy 显示文摘	Yap R Veliceasa D Emmenegger U	2005	Clin Cancer Res2005，11，18：	1
16	Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma(PPARgamma)显示文摘	Biyashev D Veliceasa D Kwiatek A	2010	J Biol Chem2010，285，13：	1
17	The many facets of PEDF in drug discovery and disease:a diamond in the rough or split personality disorder显示文摘	Craword SE Fitchev P Veliceasa D Volpert OV		0，，：	1
18	Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effectof the thrombospondin pep tide ABT-510:a comp lementation antiangiogenic strategy显示文摘	Yap R Veliceasa D Emmenegger U	2005	Clin Cancer Res2005，11，18：	1
19	Minimally invasive pereuta- neous screws osteosynthesis indications in tibial pilon fractures 显示文摘	Puha B Veliceasa B Alexa O	2012	Rev Med Chir Soc Med Nat Iasi2012，116，2：	1
20	Percutaneous pinning for proximal humerus fractures 显示文摘	Alexa O Puha B Veliceasa B	2007	Rev Med Chir Soc Med Nat Lasi2007，111，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示